PACAP27 is Protective Against Tat-Induced Neurotoxicity

Motile Axonal Mitochondria Contribute to the Variability of Presynaptic Strength

(2013) Tao Sun et al.   Cell Reports

Receptor-independent cellular uptake of pituitary adenylate cyclase-activating polypeptide

(2012) Ngoc-Duc Doan et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

Accumulation of nuclear and mitochondrial DNA damage in the frontal cortex cells of patients with HIV-associated neurocognitive disorders

(2012) Yulin Zhang et al.   BRAIN RESEARCH

Mitochondria: Mitochondrial membranes in brain ageing and neurodegeneration

(2012) Janett Eckmann et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Effects of PACAP on Intracellular Signaling Pathways in Human Retinal Pigment Epithelial Cells Exposed to Oxidative Stress

(2012) E. Fabian et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Ketone bodies protection against HIV-1 Tat-induced neurotoxicity

(2012) Liang Hui et al.   JOURNAL OF NEUROCHEMISTRY

Catechins protect neurons against mitochondrial toxins and HIV proteins via activation of the BDNF pathway

(2012) Samir Nath et al.   JOURNAL OF NEUROVIROLOGY

Mitochondrial dynamics in neurodegeneration

(2012) Kie Itoh et al.   TRENDS IN CELL BIOLOGY

Review on the Protective Effects of PACAP in Models of Neurodegenerative Diseases In Vitro and In Vivo

(2011) D. Reglodi et al.   CURRENT PHARMACEUTICAL DESIGN

Pituitary adenylate cyclase-activating peptide induces long-lasting neuroprotection through the induction of activity-dependent signaling via the cyclic AMP response element-binding protein-regulated transcription co-activator 1

(2011) Paul S. Baxter et al.   JOURNAL OF NEUROCHEMISTRY

DNA repair deficiency in neurodegeneration

(2011) Dennis Kjølhede Jeppesen et al.   PROGRESS IN NEUROBIOLOGY

Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)/PAC1HOP1 Receptor Activation Coordinates Multiple Neurotrophic Signaling Pathways

(2010) Victor May et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Regulation of Oxidative Stress by Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Mediated by PACAP Receptor

(2010) Hirokazu Ohtaki et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

(2010) Robert K. Heaton et al.   JOURNAL OF NEUROVIROLOGY

Molecular Pathology of Neuro-AIDS (CNS-HIV)

(2009) Leslie Crews et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

RANTES release contributes to the protective action of PACAP38 against sodium nitroprusside in cortical neurons

(2009) Alma Sanchez et al.   NEUROPEPTIDES

Role of Tat Protein in HIV Neuropathogenesis

(2009) Wenxue Li et al.   NEUROTOXICITY RESEARCH

Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery

(2009) D. Vaudry et al.   PHARMACOLOGICAL REVIEWS

Accumulation of nuclear DNA damage or neuron loss: Molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases

(2008) Ivona Brasnjevic et al.   DNA REPAIR

Human Immunodeficiency Virus Protein Tat Induces Synapse Loss via a Reversible Process That Is Distinct from Cell Death

(2008) H. J. Kim et al.   JOURNAL OF NEUROSCIENCE

NMDA Receptor Activation by HIV-Tat Protein Is Clade Dependent

(2008) W. Li et al.   JOURNAL OF NEUROSCIENCE

HIV-1 Tat Activates Neuronal Ryanodine Receptors with Rapid Induction of the Unfolded Protein Response and Mitochondrial Hyperpolarization

(2008) John P. Norman et al.   PLoS One

PACAP38 protects rat cortical neurons against the neurotoxicity evoked by sodium nitroprusside and thrombin

(2008) Alma Sanchez et al.   REGULATORY PEPTIDES